BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28279705)

  • 1. Lower Placebo Responses After Long-Term Exposure to Fibromyalgia Pain.
    Kosek E; Rosen A; Carville S; Choy E; Gracely RH; Marcus H; Petzke F; Ingvar M; Jensen KB
    J Pain; 2017 Jul; 18(7):835-843. PubMed ID: 28279705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
    Jensen KB; Petzke F; Carville S; Choy E; Fransson P; Gracely RH; Vitton O; Marcus H; Williams SC; Ingvar M; Kosek E
    J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
    Staud R; Lucas YE; Price DD; Robinson ME
    J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
    Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
    Arnold LM; Palmer RH; Gendreau RM; Chen W
    Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
    Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
    J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
    J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous pain modulation in response to exercise in patients with rheumatoid arthritis, patients with chronic fatigue syndrome and comorbid fibromyalgia, and healthy controls: a double-blind randomized controlled trial.
    Meeus M; Hermans L; Ickmans K; Struyf F; Van Cauwenbergh D; Bronckaerts L; De Clerck LS; Moorken G; Hans G; Grosemans S; Nijs J
    Pain Pract; 2015 Feb; 15(2):98-106. PubMed ID: 24528544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-related pain modulation in fibromyalgia: Differentiating between static versus dynamic pain indicators.
    de la Coba P; Bruehl S; Duschek S; Reyes Del Paso GA
    Int J Psychophysiol; 2018 Dec; 134():79-85. PubMed ID: 30321563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
    Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
    Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.
    Häuser W; Sarzi-Puttini P; Tölle TR; Wolfe F
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):78-87. PubMed ID: 23137770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Morphine and Naloxone on Pain Modulation in Rheumatoid Arthritis, Chronic Fatigue Syndrome/Fibromyalgia, and Controls: A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study.
    Hermans L; Nijs J; Calders P; De Clerck L; Moorkens G; Hans G; Grosemans S; Roman De Mettelinge T; Tuynman J; Meeus M
    Pain Pract; 2018 Apr; 18(4):418-430. PubMed ID: 28722815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.
    Arnold LM; Schikler KN; Bateman L; Khan T; Pauer L; Bhadra-Brown P; Clair A; Chew ML; Scavone J;
    Pediatr Rheumatol Online J; 2016 Jul; 14(1):46. PubMed ID: 27475753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia.
    Petzke F; Jensen KB; Kosek E; Choy E; Carville S; Fransson P; Williams SCR; Marcus H; Mainguy Y; Ingvar M; Gracely RH
    Scand J Pain; 2013 Apr; 4(2):65-74. PubMed ID: 29913906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.
    Clauw DJ; Mease PJ; Palmer RH; Trugman JM; Wang Y
    Arthritis Res Ther; 2013 Aug; 15(4):R88. PubMed ID: 23953493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.
    Glass JM; Williams DA; Fernandez-Sanchez ML; Kairys A; Barjola P; Heitzeg MM; Clauw DJ; Schmidt-Wilcke T
    J Pain; 2011 Dec; 12(12):1219-29. PubMed ID: 21945593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain physiology education improves health status and endogenous pain inhibition in fibromyalgia: a double-blind randomized controlled trial.
    Van Oosterwijck J; Meeus M; Paul L; De Schryver M; Pascal A; Lambrecht L; Nijs J
    Clin J Pain; 2013 Oct; 29(10):873-82. PubMed ID: 23370076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.